- Home
- FORR vs DERM Comparison
FORR vs DERM Comparison
Compare FORR & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- DERM
- Stock Information
- Founded
- FORR 1983
- DERM 2014
- Country
- FORR United States
- DERM United States
- Employees
- FORR N/A
- DERM N/A
- Industry
- FORR Diversified Commercial Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- FORR Consumer Discretionary
- DERM Health Care
- Exchange
- FORR Nasdaq
- DERM Nasdaq
- Market Cap
- FORR 179.6M
- DERM 181.0M
- IPO Year
- FORR 1996
- DERM 2021
- Fundamental
- Price
- FORR $10.63
- DERM $8.06
- Analyst Decision
- FORR
- DERM Strong Buy
- Analyst Count
- FORR 0
- DERM 2
- Target Price
- FORR N/A
- DERM $10.00
- AVG Volume (30 Days)
- FORR 68.0K
- DERM 103.3K
- Earning Date
- FORR 05-06-2025
- DERM 05-14-2025
- Dividend Yield
- FORR N/A
- DERM N/A
- EPS Growth
- FORR N/A
- DERM N/A
- EPS
- FORR N/A
- DERM N/A
- Revenue
- FORR $422,269,000.00
- DERM $56,243,000.00
- Revenue This Year
- FORR N/A
- DERM $29.83
- Revenue Next Year
- FORR $2.04
- DERM $54.88
- P/E Ratio
- FORR N/A
- DERM N/A
- Revenue Growth
- FORR N/A
- DERM N/A
- 52 Week Low
- FORR $8.50
- DERM $3.54
- 52 Week High
- FORR $20.62
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- FORR 55.44
- DERM 65.90
- Support Level
- FORR $10.39
- DERM $6.55
- Resistance Level
- FORR $10.91
- DERM $7.00
- Average True Range (ATR)
- FORR 0.46
- DERM 0.63
- MACD
- FORR 0.00
- DERM 0.13
- Stochastic Oscillator
- FORR 67.59
- DERM 92.41
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.